InChI=1S/C15H10O6/c16- 8- 4- 11(18) 9- 6- 13(20) 15(21- 14(9) 5- 8) 7- 1- 2- 10(17) 12(19) 3- 7/h1- 6H,(H4- ,16,17,18,19,20) /p+1 |
VEVZSMAEJFVWIL-UHFFFAOYSA-O |
Oc1cc(O)c2cc(O)c([o+]c2c1)-c1ccc(O)c(O)c1 |
|
antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenium
|
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-Benzopyrylium
|
ChemIDplus
|
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenylium
|
IUPAC
|
3,3',4',5,7-pentahydroxyflavylium
|
ChEBI
|
3,5,7,3',4'-Pentahydroxyflavylium
|
ChemIDplus
|
Cyanidin
|
KEGG COMPOUND
|
Cyanidin
|
ChemIDplus
|
Cyanidine
|
KEGG COMPOUND
|
Cyanidol
|
KEGG COMPOUND
|
13306-05-3
|
CAS Registry Number
|
ChemIDplus
|
1690254
|
Beilstein Registry Number
|
Beilstein
|
1690254
|
Reaxys Registry Number
|
Reaxys
|
23123597
|
PubMed citation
|
Europe PMC
|
23360684
|
PubMed citation
|
Europe PMC
|
23375153
|
PubMed citation
|
Europe PMC
|
23389674
|
PubMed citation
|
Europe PMC
|
|